These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Platelet shape change evoked by selective activation of P2X1 purinoceptors with alpha,beta-methylene ATP. Rolf MG; Brearley CA; Mahaut-Smith MP Thromb Haemost; 2001 Feb; 85(2):303-8. PubMed ID: 11246552 [TBL] [Abstract][Full Text] [Related]
8. No requirement of P2X1 purinoceptors for platelet aggregation. Takano S; Kimura J; Matsuoka I; Ono T Eur J Pharmacol; 1999 May; 372(3):305-9. PubMed ID: 10395026 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of the platelet P2X1 ion channel in transgenic mice generates a novel prothrombotic phenotype. Oury C; Kuijpers MJ; Toth-Zsamboki E; Bonnefoy A; Danloy S; Vreys I; Feijge MA; De Vos R; Vermylen J; Heemskerk JW; Hoylaerts MF Blood; 2003 May; 101(10):3969-76. PubMed ID: 12521992 [TBL] [Abstract][Full Text] [Related]
10. The ATP-gated P2X1 receptor plays a pivotal role in activation of aspirin-treated platelets by thrombin and epinephrine. Grenegård M; Vretenbrant-Oberg K; Nylander M; Désilets S; Lindström EG; Larsson A; Ramström I; Ramström S; Lindahl TL J Biol Chem; 2008 Jul; 283(27):18493-504. PubMed ID: 18480058 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of platelet functions and thrombosis through selective or nonselective inhibition of the platelet P2 receptors with increasing doses of NF449 [4,4',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis-(carbonylimino)))tetrakis-benzene-1,3-disulfonic acid octasodium salt]. Hechler B; Magnenat S; Zighetti ML; Kassack MU; Ullmann H; Cazenave JP; Evans R; Cattaneo M; Gachet C J Pharmacol Exp Ther; 2005 Jul; 314(1):232-43. PubMed ID: 15792995 [TBL] [Abstract][Full Text] [Related]
12. Potentiation of platelet activation through the stimulation of P2X1 receptors. Erhardt JA; Pillarisetti K; Toomey JR J Thromb Haemost; 2003 Dec; 1(12):2626-35. PubMed ID: 14675100 [TBL] [Abstract][Full Text] [Related]
14. A major role for P2X1 receptors in the early collagen-evoked intracellular Ca2+ responses of human platelets. Fung CY; Brearley CA; Farndale RW; Mahaut-Smith MP Thromb Haemost; 2005 Jul; 94(1):37-40. PubMed ID: 16113781 [TBL] [Abstract][Full Text] [Related]
15. Activation of receptor-operated cation channels via P2X1 not P2T purinoceptors in human platelets. MacKenzie AB; Mahaut-Smith MP; Sage SO J Biol Chem; 1996 Feb; 271(6):2879-81. PubMed ID: 8621673 [TBL] [Abstract][Full Text] [Related]
16. The novel suramin analogue NF864 selectively blocks P2X1 receptors in human platelets with potency in the low nanomolar range. Horner S; Menke K; Hildebrandt C; Kassack MU; Nickel P; Ullmann H; Mahaut-Smith MP; Lambrecht G Naunyn Schmiedebergs Arch Pharmacol; 2005 Jul; 372(1):1-13. PubMed ID: 16158305 [TBL] [Abstract][Full Text] [Related]
17. P2X1-initiated p38 signalling enhances thromboxane A2-induced platelet secretion and aggregation. Huang Z; Liu P; Zhu L; Li N; Hu H Thromb Haemost; 2014 Jul; 112(1):142-50. PubMed ID: 24633352 [TBL] [Abstract][Full Text] [Related]
18. MEK/MAPK as a signaling element in ATP control of endothelial myosin light chain. Klingenberg D; Gündüz D; Härtel F; Bindewald K; Schäfer M; Piper HM; Noll T Am J Physiol Cell Physiol; 2004 Apr; 286(4):C807-12. PubMed ID: 15001425 [TBL] [Abstract][Full Text] [Related]
19. Secreted dense granule adenine nucleotides promote calcium influx and the maintenance of elevated cytosolic calcium levels in stimulated human platelets. Lages B; Weiss HJ Thromb Haemost; 1999 Feb; 81(2):286-92. PubMed ID: 10064008 [TBL] [Abstract][Full Text] [Related]
20. Platelet Ca(2+) responses coupled to glycoprotein VI and Toll-like receptors persist in the presence of endothelial-derived inhibitors: roles for secondary activation of P2X1 receptors and release from intracellular Ca(2+) stores. Fung CY; Jones S; Ntrakwah A; Naseem KM; Farndale RW; Mahaut-Smith MP Blood; 2012 Apr; 119(15):3613-21. PubMed ID: 22228626 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]